<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Monitoring for adults with systemic anthrax</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Monitoring for adults with systemic anthrax</h1>
<div class="graphic"><div class="figure"><div class="ttl">Monitoring for adults with systemic anthrax</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Test</td> <td class="subtitle1" colspan="2">Suggestions for testing and unique findings in systemic anthrax</td> </tr> <tr> <td class="subtitle2">Initial</td> <td class="subtitle2">Serial monitoring</td> </tr> <tr class="divider_bottom"> <td>Complete blood count</td> <td> <ul> <li>Marked hemoconcentration</li> <li>Thrombocytopenia may not be present</li> <li>Leukocyte count frequently at reference level</li> </ul> </td> <td> <ul> <li>Anemia can suddenly develop</li> <li>Thrombocytopenia onset often associated with hemolytic anemia</li> <li>Leukocytosis usually not seen until late in disease</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Electrolytes, renal panel, lactate level</td> <td> <ul> <li>Decreased sodium level</li> <li>HCO<sub>3</sub> level can be at reference level even with sepsis</li> <li>Increased blood urea nitrogen level</li> </ul> </td> <td> <ul> <li>Decreased sodium level</li> <li>HCO<sub>3</sub> level can be at reference level even with sepsis</li> <li>Increased blood urea nitrogen level</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Liver enzymes, serum albumin</td> <td> <ul> <li>Mildly elevated transaminase levels</li> <li>Hypoalbuminemia related to acute infection</li> </ul> </td> <td> <ul> <li>Mildly elevated transaminase levels</li> <li>Hypoalbuminemia related to acute infection</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>PT, PTT, D-dimer, fibrinogen</td> <td> <ul> <li>Reference PT/PTT at admission does not exclude coagulopathy or disseminated intravascular coagulopathy</li> </ul> </td> <td> <ul> <li>Maintain a low threshold for hypercoagulability workup, including: <ul> <li>Haptoglobin</li> <li>Lactate dehydrogenase</li> <li>Fibrin split products</li> </ul> </li> <li>If there is evidence of hemolytic anemia, assess ADAMTS13 (von Willebrand factor-cleaving protease)</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Erythrocyte sedimentation rate, CRP</td> <td> <ul> <li>Useful for characterizing inflammatory response</li> <li>Low CRP characteristic in injection anthrax</li> </ul> </td> <td> <ul> <li>Useful for characterizing inflammatory response</li> <li>Low CRP characteristic in injection anthrax</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Gram stain, cultures, toxin assays</td> <td> <ul> <li> <p>Perform initial testing on any accessible fluid:</p> <ul> <li> <p>Blood and serum</p> </li> <li>Bronchial aspirates and pleural fluid</li> <li>Wound exudates</li> <li>Cerebrospinal fluid</li> <li>Ascites</li> </ul> </li> </ul> <p> </p> <p> </p> </td> <td> <ul> <li>Cultures usually negative after antimicrobials</li> <li>Toxin may be detectable at multiple time points</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Cardiac enzymes with or without B-type natriuretic peptide</td> <td> <ul> <li>Troponin leak caused by increased cardiac demands from acute infection (especially if atrial fibrillation with rapid ventricular response)</li> </ul> </td> <td> <ul> <li>Troponin leak caused by increased cardiac demands from acute infection (especially if atrial fibrillation with rapid ventricular response).</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Electrocardiogram/continuous telemetry</td> <td> <ul> <li>Atrial fibrillation with rapid ventricular response.</li> </ul> </td> <td> <ul> <li>Atrial fibrillation with rapid ventricular response.</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Posterior-anterior and lateral chest radiograph</td> <td> <ul> <li>Any abnormality could be consistent</li> <li>Characteristic mediastinal widening and pleural effusions may be subtle or inapparent</li> </ul> </td> <td> <ul> <li>Perform daily chest radiographs or other thoracic imaging until pleural effusions are stable or decreasing</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Chest computerized tomography</td> <td> <ul> <li>To evaluate for severity of pleural effusions, presence of mediastinal widening or pericardial effusion, and to rule out thromboembolic disease</li> </ul> </td> <td> <ul> <li>Repeat if major clinical status change</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Lumbar puncture</td> <td> <ul> <li>Perform at admission unless contraindicated</li> </ul> </td> <td> <ul> <li>Perform for headache/confusion or other neurologic symptoms</li> <li>Meningeal signs are usually not present until late stage if meningitis is present.</li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Other imaging</td> <td> <ul> <li>Perform as relevant to site of exposure to evaluate edema, inflammation, and necrosis.</li> </ul> </td> <td> <ul> <li>Perform neuroimaging for headache/confusion or other neurologic symptoms</li> <li>Meningeal signs are usually not present until late stage if meningitis is present</li> </ul> </td> </tr> <tr> <td>Echocardiogram</td> <td> <ul> <li>To evaluate for pericardial effusion and myocardial dysfunction</li> </ul> </td> <td> <ul> <li>To evaluate for pericardial effusion and myocardial dysfunction</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">Medical history, physical examination, and vital signs with pulse oximetry at admission should be followed up by regular careful monitoring. This applies even in patients who appear clinically improved because of the potential for sudden decompensation. Although standard blood work and diagnostic tests are recommended to evaluate acute infectious illnesses, anthrax is associated with unique findings.</div><div class="graphic_footnotes">PT: prothrombin time; PTT: partial thromboplastin time; ADAMTS 13: a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; CRP: C-reactive protein.<br/></div><div class="graphic_reference">Reproduced from: Centers for Disease Control and Prevention. United States Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults, 2014. Available at: <a href="https://wwwnc.cdc.gov/eid/article/20/2/13-0687-techapp1.pdf" target="_blank">https://wwwnc.cdc.gov/eid/article/20/2/13-0687-techapp1.pdf</a> (Accessed on November 29, 2018).</div><div id="graphicVersion">Graphic 119773 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
